Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2011) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacology and Therapeutics | journal | 3.411 Q1 | 233 | 101 | 299 | 18833 | 3024 | 296 | 9.74 | 186.47 |  |
| 2 | Expert Opinion on Emerging Drugs | journal | 0.973 Q1 | 54 | 45 | 135 | 5658 | 526 | 135 | 3.97 | 125.73 |  |
| 3 | Drug Resistance Updates | journal | 4.917 Q1 | 132 | 27 | 51 | 3149 | 625 | 50 | 10.57 | 116.63 | |
| 4 | Drug Metabolism Reviews | journal | 1.395 Q1 | 108 | 38 | 89 | 4163 | 449 | 85 | 5.00 | 109.55 | |
| 5 | Side Effects of Drugs Annual | book series | 0.106 Q4 | 9 | 52 | 157 | 5441 | 4 | 53 | 0.02 | 104.63 |  |
| 6 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.389 Q2 | 30 | 26 | 79 | 2513 | 106 | 79 | 1.27 | 96.65 | |
| 7 | Neurotherapeutics | journal | 2.457 Q1 | 136 | 68 | 193 | 6372 | 1459 | 180 | 6.63 | 93.71 | |
| 8 | Drugs | journal | 1.490 Q1 | 188 | 144 | 494 | 13027 | 2664 | 460 | 5.62 | 90.47 | |
| 9 | CNS Neuroscience and Therapeutics | journal | 1.437 Q1 | 91 | 83 | 118 | 6890 | 558 | 110 | 4.46 | 83.01 | |
| 10 | AIDS Reviews | journal | 1.932 Q1 | 62 | 28 | 77 | 2316 | 319 | 62 | 3.43 | 82.71 |  |
| 11 | Journal of Dietary Supplements | journal | 0.128 Q4 | 38 | 23 | 91 | 1894 | 25 | 89 | 0.33 | 82.35 | |
| 12 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 47 | 4 | 0 | 327 | 0 | 0 | 0.00 | 81.75 | | |
| 13 | Expert Review of Neurotherapeutics | journal | 1.162 Q1 | 98 | 175 | 490 | 13715 | 1705 | 407 | 3.58 | 78.37 | |
| 14 | Expert Opinion on Investigational Drugs | journal | 1.541 Q1 | 117 | 142 | 487 | 11009 | 2256 | 471 | 4.88 | 77.53 | |
| 15 | CNS Drugs | journal | 1.557 Q1 | 129 | 80 | 233 | 6074 | 1417 | 218 | 6.05 | 75.93 | |
| 16 | Expert Review of Clinical Pharmacology | journal | 0.297 Q3 | 60 | 69 | 197 | 5043 | 143 | 167 | 0.77 | 73.09 | |
| 17 | Expert Opinion on Pharmacotherapy | journal | 0.800 Q2 | 93 | 259 | 847 | 18824 | 2415 | 814 | 2.99 | 72.68 | |
| 18 | Cardiovascular Therapeutics | journal | 0.700 Q2 | 54 | 57 | 128 | 3887 | 288 | 115 | 2.19 | 68.19 | |
| 19 | Frontiers in Pharmacology | journal | 0.166 Q3 | 154 | 88 | 41 | 5841 | 32 | 41 | 0.78 | 66.38 |  |
| 20 | Biologics: Targets and Therapy | journal | 0.645 Q2 | 47 | 7 | 149 | 456 | 323 | 149 | 2.68 | 65.14 |  |
| 21 | Expert Opinion on Drug Safety | journal | 0.863 Q2 | 90 | 86 | 229 | 5576 | 737 | 208 | 3.52 | 64.84 | |
| 22 | Journal of Psychiatry and Neuroscience | journal | 2.248 Q1 | 114 | 43 | 163 | 2788 | 768 | 138 | 4.70 | 64.84 |  |
| 23 | Therapeutic Advances in Respiratory Disease | journal | 0.809 Q2 | 50 | 34 | 100 | 2123 | 277 | 98 | 2.48 | 62.44 | |
| 24 | Paediatric Drugs | journal | 0.675 Q2 | 70 | 41 | 132 | 2512 | 318 | 118 | 2.37 | 61.27 | |
| 25 | Journal of Psychopharmacology | journal | 1.194 Q1 | 135 | 166 | 501 | 10159 | 1617 | 451 | 3.18 | 61.20 | |
| 26 | Experimental and Clinical Psychopharmacology | journal | 1.214 Q1 | 101 | 43 | 163 | 2611 | 478 | 163 | 2.66 | 60.72 | |
| 27 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 18 | 11 | 1092 | 22 | 11 | 2.00 | 60.67 | | |
| 28 | Targeted Oncology | journal | 0.985 Q1 | 59 | 29 | 98 | 1731 | 266 | 85 | 3.89 | 59.69 |  |
| 29 | OncoTargets and Therapy | journal | 0.588 Q2 | 86 | 19 | 45 | 1125 | 90 | 45 | 2.00 | 59.21 | |
| 30 | Drugs of the Future | journal | 0.221 Q3 | 46 | 104 | 343 | 6120 | 197 | 342 | 0.59 | 58.85 | |
| 31 | Cancer and Chemotherapy Reviews | journal | 0.104 Q4 | 4 | 19 | 53 | 1113 | 2 | 53 | 0.03 | 58.58 | |
| 32 | Expert Review of Anticancer Therapy | journal | 1.041 Q1 | 85 | 207 | 535 | 12125 | 1422 | 457 | 2.75 | 58.57 | |
| 33 | Therapy | journal | 0.138 Q3 | 22 | 73 | 261 | 4241 | 63 | 182 | 0.19 | 58.10 | |
| 34 | International Journal of Neuropsychopharmacology | journal | 1.998 Q1 | 125 | 116 | 370 | 6709 | 1789 | 343 | 4.47 | 57.84 | |
| 35 | Drugs of Today | journal | 0.422 Q2 | 57 | 73 | 295 | 4139 | 475 | 290 | 1.69 | 56.70 | |
| 36 | Clinical Pharmacokinetics | journal | 1.861 Q1 | 184 | 61 | 180 | 3425 | 1157 | 165 | 5.84 | 56.15 | |
| 37 | Drugs and Aging | journal | 0.919 Q2 | 109 | 91 | 255 | 5034 | 849 | 245 | 3.25 | 55.32 | |
| 38 | Journal des Anti-Infectieux | journal | 0.132 Q4 | 6 | 31 | 0 | 1707 | 0 | 0 | 0.00 | 55.06 | |
| 39 | European Neuropsychopharmacology | journal | 1.625 Q1 | 130 | 99 | 322 | 5365 | 1419 | 317 | 4.16 | 54.19 | |
| 40 | Infection and Drug Resistance | journal | 0.123 Q4 | 65 | 24 | 9 | 1292 | 2 | 8 | 0.22 | 53.83 | |
| 41 | BioDrugs | journal | 1.486 Q1 | 79 | 48 | 120 | 2573 | 568 | 114 | 4.12 | 53.60 | |
| 42 | Therapeutic Advances in Drug Safety | journal | 0.105 Q4 | 46 | 23 | 7 | 1204 | 2 | 4 | 0.29 | 52.35 | |
| 43 | Current Treatment Options in Oncology | journal | 1.353 Q1 | 66 | 32 | 76 | 1653 | 257 | 73 | 3.29 | 51.66 | |
| 44 | Therapeutic Advances in Cardiovascular Disease | journal | 0.726 Q2 | 41 | 26 | 120 | 1314 | 295 | 112 | 2.14 | 50.54 | |
| 45 | Current Cardiovascular Risk Reports | journal | 0.309 Q3 | 34 | 72 | 216 | 3634 | 122 | 210 | 0.51 | 50.47 | |
| 46 | Orphanet Journal of Rare Diseases | journal | 2.181 Q1 | 136 | 88 | 104 | 4396 | 822 | 104 | 6.59 | 49.95 | |
| 47 | Journal of International Peacekeeping | journal | 0.156 Q3 | 14 | 17 | 45 | 849 | 33 | 41 | 0.97 | 49.94 | |
| 48 | PPAR Research | journal | 0.929 Q2 | 59 | 19 | 215 | 948 | 480 | 202 | 1.78 | 49.89 | |
| 49 | Pharmacopsychiatry | journal | 0.834 Q2 | 84 | 62 | 212 | 3056 | 451 | 173 | 2.16 | 49.29 |  |
| 50 | Inflammopharmacology | journal | 0.849 Q2 | 68 | 36 | 102 | 1754 | 311 | 99 | 2.47 | 48.72 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data